| RS1568724130 |
FAM20A
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS1568724567 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1568725026 |
ACTN4
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 1, Focal segmental glomerulosclerosis 1 |
| RS1568725951 |
ABHD12
|
Health Risk |
Pathogenic |
Cone dystrophy, Cone dystrophy |
| RS1568731279 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Type 2 diabetes mellitus |
| RS1568731526 |
GDF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Grebe syndrome, Grebe syndrome |
| RS1568733815 |
AVP
|
Health Risk |
Pathogenic |
— |
| RS1568741207 |
HNF4A
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1568741527 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1568748859 |
ELMO2
|
Health Risk |
Likely pathogenic |
Primary intraosseous venous malformation, Primary intraosseous venous malformation |
| RS1568757730 |
DPM1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type 1E |
| RS1568760224 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1568761792 |
CTSA
|
Health Risk |
Pathogenic |
— |
| RS1568762986 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1568763104 |
PLCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Uveal melanoma, Ocular melanocytosis |
| RS1568786761 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1568789814 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1568791022 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568791393 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568791694 |
JAG1
|
Health Risk |
Likely pathogenic |
Arteriohepatic dysplasia, Arteriohepatic dysplasia |
| RS1568791920 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568792051 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568792125 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568792238 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1568792286 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568792344 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568793232 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568793265 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568793309 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568793670 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568794128 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568794159 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568795820 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568796003 |
RPS19
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 1, Diamond-Blackfan anemia 1 |
| RS1568796158 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568796236 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS1568796241 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568796298 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568796883 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568798024 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568798248 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS1568798289 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568798388 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568801068 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568801096 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568801716 |
CD79A
|
Health Risk |
Pathogenic |
Agammaglobulinemia 3, autosomal recessive |
| RS1568806160 |
CEP250
|
Health Risk |
Pathogenic/Likely pathogenic |
CEP250-related disorder, CEP250-related disorder |
| RS1568807044 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568807161 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS1568807297 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, SOD1-related disorder |
| RS1568807314 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568807342 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568807400 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568807463 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568807483 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1568809149 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568809169 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568809172 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810275 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810316 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810641 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810660 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810686 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810715 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568810771 |
SOD1
|
Health Risk |
Likely pathogenic |
Spastic tetraplegia and axial hypotonia, progressive |
| RS1568810789 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811366 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811372 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811423 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811426 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811445 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811454 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811489 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811515 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1568811520 |
SOD1
|
Health Risk |
Likely pathogenic |
— |
| RS1568820302 |
CEP250
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS1568822376 |
ZNF335
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism due to ZNF335 deficiency, Microcephalic primordial dwarfism due to ZNF335 deficiency |
| RS1568823467 |
EDN3
|
Health Risk |
risk factor |
Hirschsprung disease, susceptibility to |
| RS1568823517 |
EDN3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4B, Waardenburg syndrome type 4B |
| RS1568835906 |
KCNE1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 5, Long QT syndrome 5 |
| RS1568836235 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1568836457 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 5, Long QT syndrome |
| RS1568836956 |
KCNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 5, Long QT syndrome |
| RS1568839335 |
CLDN14
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 29, Autosomal recessive nonsyndromic hearing loss 29 |
| RS1568844677 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1568845361 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1568853466 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS1568857280 |
DNMT3B
|
Health Risk |
Pathogenic |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS1568858210 |
TNNI3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1568858517 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS1568858567 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1568864658 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568864697 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1568865283 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1568865669 |
DNAAF3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia 2 |
| RS1568866374 |
SALL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Oculootoradial syndrome, Duane-radial ray syndrome |
| RS1568879914 |
ITGB2
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1568883795 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1568890288 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1568893029 |
COL18A1
|
Health Risk |
Pathogenic |
— |